Introduction

H. GOOSSENS (Antwerp, Belgium)

Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Number: 0
Disease area: Respiratory infections

Webcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. GOOSSENS (Antwerp, Belgium). Introduction. Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007


Lower respiratory tract infections: when are antibiotics mandatory?
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=146
Year: 2004

Relevance of correct antibiotic choice in community-acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


Defining stability in pneumonia and the non-responding pneumonia
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005

Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011



Pulmonary infections in HIV-infected patients: an update in the 21st century
Source: Eur Respir J 2012; 39: 730-745
Year: 2012



Human metapneumovirus and community-acquired pneumonia: a pediatric survey
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


PATS and ERS paediatric webinar: reducing the burden of CAP
Source: ERS webinar 2021: PATS and ERS paediatric webinar: reducing the burden of CAP
Year: 2021

Corticosteroids in severe pneumonia
Source: Eur Respir J 2008; 32: 259-264
Year: 2008



Current treatments for respiratory infections in children
Source: Annual Congress 2005 - PG5 - Paediatrics: respiratory infections in children
Year: 2005


Clostridium difficile infection following community-acquired pneumonia
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011

Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007



Antibiotics and new guidelines for the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175
Year: 2004

Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007


Virusologic research in healthy persons of closed collectives
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005


Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002



Improving outcome in elderly patients with pneumonia
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005